Sibold William John 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Sep 11, 2024
Insider Transaction Report
Form 4
Sibold William John
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-09-09$243.83/sh−6,363$1,551,490→ 55,887 total
Footnotes (1)
- [F1]The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.